MEDICAMeet Sobel at MEDICA 2026Düsseldorf, 16–19 Nov.Book a meeting with us →Book a meeting

Home › Solutions › Medical devices › Brazil

MEDICAL DEVICES · BRAZIL

ANVISA registration for medical devices in Brazil.

From classification to post-market, Sobel turns ANVISA requirements into clear decisions, structured execution and secure market access for your device.

ISO 9001 certified in BrazilTop Medical Device Consultant · LatAm 2025Service in PT · EN · DE

WHY BRAZIL

A market that buys what it doesn’t make

#1

Largest healthcare market in Latin America

Health spending of 9.7% of GDP (IBGE, 2021).

US$ 10.2 bn

Medical devices imported in 2025

Up 10.9% on 2024. Imports exceed exports by US$ 9.2 billion.

MDSAP

A recognized regulatory system

ANVISA is one of the five MDSAP authorities, with the US, Canada, Japan and Australia. In 2024, 61% of the GMP certificates it issued were based on MDSAP audit reports.

Sources: IBGE, Conta-Satélite de Saúde (2021 data) and U.S. International Trade Administration; ABIIS economic bulletin, March 2026 (Comex Stat data); ANVISA, MDSAP use in Brazil (IMDRF, 2026).

IS THIS FOR YOU?

Who we do this for

Brazil is your first market

You need the right class and route before any file is built.

Book a Brazil assessment →

You already have CE or FDA

You want to reuse your technical documentation and add only what Brazil requires.

See the pathway ↓

You need a new holder

Your registration is held by a distributor and you want an independent holder.

Brazilian Registration Holder →

Your submission is stuck

A technical requirement, a rejection or months without an answer from ANVISA.

Product stuck at ANVISA? →

BRAZIL ESSENTIALS

Where does your device fit?

Classes I and II follow notification, Classes III and IV need registration.

Hover over or tap a product to see what each class requires.

Class I

Low risk

Notification · simpler path

Examples: Stethoscopes, reusable surgical instruments, non-sterile bandages.

What it takes in Brazil

  • Notification to ANVISA
  • Technical documentation kept by the holder
  • No BGMP certificate required

In every class: a Brazilian holder, labels and IFU in Portuguese, and INMETRO or Anatel when applicable.

Class II

Medium risk

Notification · simpler path

Examples: Syringes, hearing aids, diagnostic ultrasound.

What it takes in Brazil

  • Notification to ANVISA
  • Technical documentation kept by the holder
  • No BGMP certificate required

In every class: a Brazilian holder, labels and IFU in Portuguese, and INMETRO or Anatel when applicable.

Class III

High risk

Registration · more complex review

Examples: Infusion pumps, orthopedic implants and bone screws.

What it takes in Brazil

  • Registration with a full technical dossier
  • BGMP certificate, which an MDSAP report can support
  • Biological and clinical evidence

In every class: a Brazilian holder, labels and IFU in Portuguese, and INMETRO or Anatel when applicable.

Class IV

Highest risk

Registration · more complex review

Examples: Heart valves, breast implants, coronary stents.

What it takes in Brazil

  • Registration with a full technical dossier
  • BGMP certificate, which an MDSAP report can support
  • Robust clinical evidence, often with clinical data

In every class: a Brazilian holder, labels and IFU in Portuguese, and INMETRO or Anatel when applicable.

Examples are illustrative: the final class depends on the device and its intended use under RDC 751/2022. Working with IVDs? See IVD · Brazil →

THE BRAZIL PATHWAY

The full lifecycle of your device in Brazil

Step 01

Strategy & classification

Before any document is written, we define the risk class under RDC 751/2022, the route (notification or registration) and what each target market will require.

What we deliver

  • Risk classification
  • Regulatory route per market
  • Gap overview and priorities
Young woman in a manufacturer environment. She is checking the data, on a quality control process.

Step 02

Quality system

Your QMS aligned with ISO 13485 and RDC 665/2022, with BGMP certification support when required and MDSAP readiness for multi-market access.

What we deliver

  • Gap analysis (RDC 665 / ISO 13485)
  • Internal audits
  • BGMP and MDSAP support
Two specialists working on a QMS for medical devices.

Step 03

Safety & clinical evidence

Biological and clinical evaluation built once and reused across markets. We review existing data first and test only where data is missing.

What we deliver

  • BEP and BER (ISO 10993-1:2025)
  • Toxicological risk assessment (ISO 10993-17)
  • CEP and CER
Man at a office desk, looking one document. There is a pile of documents aside him.

Step 04

Technical file & certifications

The technical dossier organized the way ANVISA reviews it, with IFU and labels in Portuguese and the INMETRO or Anatel certificate when your device needs one.

What we deliver

  • Technical dossier and critical review
  • IFU and labels in Portuguese
  • INMETRO or Anatel certification
Team working on quality control system. There are three persons, checking charts and data.

Step 05

Submission & approval

Filing, follow-up and answers to ANVISA requirements until publication.

What we deliver

  • Notification (Classes I and II)
  • Registration (Classes III and IV)
  • Answers to requirements (exigências)

Step 06

Local representation

Foreign manufacturers need a Brazilian holder for the registration. Our qualified partner acts as holder, independent from your distributors.

What we deliver

  • Brazilian Registration Holder
  • Technovigilance and contact with ANVISA
  • Freedom to change distributors
Man holding a magnifying glass while analyzing documents

Step 07

Post-market

Keep your product compliant after approval: changes, new models, revalidation every 10 years and vigilance, with a regulatory team on demand.

What we deliver

  • Changes and new models
  • Revalidations
  • Ongoing regulatory support

SERVICES IN BRAZIL

ANVISA services for medical devices

STEP 01

Regulatory Strategy & Classification

Know your class and route before you invest.

Ideal for: first-time entry into Brazil

STEP 02

QMS, BGMP & MDSAP

A quality system ready for ANVISA inspection.

Ideal for: manufacturers in Brazil and abroad

STEP 03

Biological & Clinical Evaluation

Safety and clinical evidence built once, reused across markets.

Ideal for: devices in contact with the body

STEPS 04–05

ANVISA Registration & Notification

Dossier, submission and follow-up until publication.

Ideal for: every device entering Brazil

STEP 04

INMETRO & Anatel

Certification for electromedical and connected devices.

Ideal for: electromedical devices

STEP 06

Brazilian Registration Holder

Your Brazilian holder through our qualified partner, without opening a company.

Ideal for: foreign manufacturers

Working with IVDs? See IVD · Brazil →

RECOMMENDED FOR FOREIGN MANUFACTURERS

ANVISA Entry Package

Everything you need to place your device on the Brazilian market, coordinated by one team and one contact.

Classification & route

Risk class and notification or registration path.

Technical file

Dossier, Portuguese IFU and labels.

Submission & follow-up

Filing, requirements and publication.

Registration holder, year one

Local representation and vigilance.

Optional: INMETRO / Anatel · BGMP certification support · sworn translations

HOW WE WORK WITH YOU

Start with a project. Stay with a partner.

Pick the model that fits where your device is today, and switch when it changes.

Project

Regulatory Projects

You have a device to launch or a problem to solve now.

What you get

Partnership

Ongoing Support

Your devices are on the market, and the rules keep moving.

What you get

Why Sobel

Regulation as a business decision, not a checklist.

Four disciplines work on every project, in the same team, from the first decision to post-market.

Strategy

Classification and market sequence decided first. The right class from day one avoids rework.

Science in house

Biological, clinical and toxicological evaluation by our own Clinical Evidence & Product Safety team.

Regulatory, five markets

ANVISA, FDA, EU MDR, MHRA and Health Canada, coordinated together.

Technology

A dedicated technology team builds the workflows that keep every project traceable and on time.

“We know how auditors think, because we’ve been one of them.”

Maik Endler

Founder & CEO

  • Mechanical engineer, trained in Germany
  • Former BSI auditor (Notified Body)
  • Industry experience at Sirona (now Dentsply Sirona)

CLIENT VOICES

Trusted for decisions that move products forward.

“

Fast solutions, focused on your goals

“Sobel provided a friendly, goal-oriented service with fast solutions. We look forward to working together on future projects.”

Andreas Kohl, CEO of Andratec

Andreas Kohl

CEO · Andratec

“

Broad expertise, real collaboration

“I experienced always supportive, pro-active collaboration from Sobel Consult with high degree of competency in broad regulatory range.”

Mandy Blocher, Aesculap AG (B. Braun)

Mandy Blocher

Expert Regulatory Framework & Digital Transformation · Aesculap AG (B. Braun)

Clear regulatory direction icon

Clear regulatory direction

The right pathway and priorities for your product.

Fast and responsive support icon

Fast and responsive support

We act quickly to keep projects moving.

Practical guidance icon

Practical guidance

Actionable advice for your next step.

FAQ

Questions we hear before every first call

Clear answers to what manufacturers ask us most about ANVISA registration for medical devices in Brazil.

Ask your question →
What are the main regulations for medical devices in Brazil?

Medical devices are regulated by ANVISA. The core rules are RDC 751/2022 (classification, notification and registration), RDC 665/2022 (Good Manufacturing Practices) and the post-market rules for technovigilance. Electromedical and wireless devices may also need INMETRO and Anatel certification.

How are medical devices classified in Brazil?

Under RDC 751/2022, devices fall into four risk classes: Class I (low), II (medium), III (high) and IV (highest). The class depends on the intended use, invasiveness and duration of contact, and it defines the route to market. See where your device fits.

What is the difference between notification and registration?

Notification applies to Classes I and II and requires a simplified dossier. Registration applies to Classes III and IV and requires a complete technical dossier, B-GMP certification and technical review by ANVISA before approval.

Can a foreign manufacturer register a device in Brazil without a local company?

No. The notification or registration must be held by a company established in Brazil. A Brazilian Registration Holder can hold it on your behalf, so you keep control of your registrations and stay free to choose your distributors. Sobel offers this service through a qualified partner. Learn about our Registration Holder service.

What are ANVISA’s GMP requirements for medical devices?

Manufacturers of Class III and IV devices need ANVISA’s Good Manufacturing Practices certificate (B-GMP, or CBPF). Under RDC 850/2024, when it is granted through an MDSAP audit report, it is valid for four years, as long as the manufacturer stays in MDSAP. See our QMS, BGMP & MDSAP support.

Is INMETRO certification always required?

No. INMETRO certification applies to electromedical equipment within its scope, and Anatel certification to devices with radio transmission. Many devices need neither. We confirm what applies during the classification step. See INMETRO & Anatel.

Can I use my CE marking or FDA clearance to register in Brazil?

ANVISA does not accept CE marking or FDA clearance on their own, but much of your technical file, test reports and clinical evidence can be reused and adapted. For some higher-risk devices approved by equivalent foreign authorities, ANVISA also offers an optimized review route.

How long is an ANVISA registration valid?

A registration (Classes III and IV) is valid for 10 years and must be renewed. A notification (Classes I and II) has no expiry date, but changes to the product must still be reported to ANVISA.

Do labels and instructions for use need to be in Portuguese?

Yes. Labels and instructions for use must be in Brazilian Portuguese and follow ANVISA’s labeling requirements, including the registration or notification number once it is granted.

How can companies monitor approval status?

Applications can be followed in ANVISA’s online systems, and decisions are published in the Official Gazette (DOU). When Sobel manages your submission, we follow it for you and prepare the answer to each ANVISA requirement within the deadline, with your team’s input.

Latest articles

Discover trends, tips, and expert insights to keep you ahead.

Newsletter

Subscribe to our newsletter to receive the latest updates and insights.

You may unsubscribe at any time using the link in our newsletter.